New Zofran (ondansetron) Case Filed Alleging Heart Defects

A new lawsuit has been filed against drug giant GlaxoSmithKline (“GSK”) alleging the Company unlawfully marketed its powerful anti-nausea drug Zofran (ondansetron) for off-label uses – in particular to curb morning sickness during the first trimester of pregnancy.

The suit claims that GSK failed to warn Zofran (ondansetron) users of the birth defect risks associated with taking the drug while pregnant, which include cleft palate and a number of heart malformations. The suit further alleges that, as a result of the drugmaker’s alleged negligent behavior, the plaintiffs’ son was born with the congenital heart defect known as bicuspid aortic stenosis and will require future surgeries and extensive monitoring to repair his heart valve.

If you or a loved one took Zofran (ondansetron) for morning sickness during pregnancy and if your child was born with a congenital heart defect or a cleft palate, call us today at 877-978-0169 for a free, private discussion of your potential claim.

Real Time Analytics